![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
High SVR12 Rates in HCV Genotype 1b-Infected Patients Receiving Ombitasvir/ABT-450/r and Dasabuvir With or Without Ribavirin Regardless of Baseline Characteristics
|
|
|
Reported by Jules Levin
54th Interscience Conference on Antimicrobial Agents & Chemotherapy
Washington, D.C., 07 September 2014
David Bernstein, Frederik Nevens, Jeffrey V. Enejosa, Federico Rodriguez-Perez, Resat Ozaras, Christophe Moreno, Maurizia R. Brunetto, Martin King, Daniel E. Cohen
![ICAAC1.gif](../images/090814/090814-12/ICAAC1.gif)
![ICAAC2.gif](../images/090814/090814-12/ICAAC2.gif)
![ICAAC3.gif](../images/090814/090814-12/ICAAC3.gif)
![ICAAC4.gif](../images/090814/090814-12/ICAAC4.gif)
![ICAAC5.gif](../images/090814/090814-12/ICAAC5.gif)
![ICAAC6.gif](../images/090814/090814-12/ICAAC6.gif)
![ICAAC7.gif](../images/090814/090814-12/ICAAC7.gif)
![ICAAC8.gif](../images/090814/090814-12/ICAAC8.gif)
![ICAAC9.gif](../images/090814/090814-12/ICAAC9.gif)
![ICAAC10.gif](../images/090814/090814-12/ICAAC10.gif)
![ICAAC11.gif](../images/090814/090814-12/ICAAC11.gif)
![ICAAC12.gif](../images/090814/090814-12/ICAAC12.gif)
![ICAAC13.gif](../images/090814/090814-12/ICAAC13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|